Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Techne Licenses Protein Synthesis Tech from MRC

NEW YORK (GenomeWeb) – Bio-Techne has licensed rights to a protein synthesis technology developed by the Medical Research Council Laboratory of Molecular Biology.

MRC Technology, the tech transfer organization for the UK's MRC, said that it has licensed to Bio-Techne the Genetically encoded Orthogonal Protection and Activated Ligation (GOPAL) technology, which enables the site-specific isopeptide bonds between proteins. The license enables the Minneapolis, Minn.-based life science research tools firm to develop reagent products using GOPAL.

According to MRC, the technology will first be applied to developing ubiquitin dimmers, with the potential for development of trimers and tetramers. It added that Bio-Techne's Boston Biochem company will investigate the use of GOPAL in "introducing post-translational modifications into proteins for structural and functional studies."

Financial and other terms of the license were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.